Navigation Links
Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
Date:1/8/2014

NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Ensil's team of researchers and engineers have developed a medical device with patented technology that will help patients who suffer from mobility issues caused by spinal cord injuries, strokes or muscle disorders.

This product is called Vastusys (www.vastusys.com), and it works by replicating normal communication between the brain and the limbs via a proprietary, patented technology developed by Ensil. The product utilizes Ensil's innovative bluetooth protocol technology and multiple sensors to enable muscle movement and improve mobility.

"This is truly a ground-breaking achievement that will improve the lives of so many people," said Mr. Farsad Kiani, CEO of Ensil Canada. "I am excited to extend an open invitation to publicly traded companies to either acquire this technology or partner with Ensil to market and distribute this medical device to people around the world."

Ensil is currently inviting publicly traded companies to express interest in either acquiring the new technology or partnering with Ensil on the marketing and/or distribution of the Vastusys medical device.

Ensil Canada is a member of the Ensil group of companies (www.ensil.com), and it focuses on enhancing mission-critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's Research and Development division's mission is to develop new technologies or improve existing technologies, leveraging its in-house aerospace, defence and medical technology expertise, research and resources.

For nearly 30 years, a fundamental belief in "Innovation Beyond Imagination" has been part of Ensil's corporate culture. Since its inception, the company has built its brand in the North American Aerospace and Defence industries as a boutique engineering and R&D technology leader that is striving to improve the quality of life of people globally via innovative ideas and technologies.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
3. Canada-based Radimetrics Announces Expansion to Scotland
4. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
5. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
6. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
7. VirtualScopics Receives Issuance of Influential Patent in Canada
8. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
9. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
10. Sensus Healthcare Announces Health Canada Approval
11. New Treatment For Obstructive Sleep Apnea Now Available In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):